Approval · Notice of Compliance 15382 · 2014
ADEMPAS: Notice of Compliance 15382
Issued March 6, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15382
- Date
- March 6, 2014
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Soluble guanylate cyclase (sgc) stimulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADEMPAS | Not yet assigned | — |